UPHealth: Healthcare & Financial Reporting
Valuation services provided to UpHealth included the purchase price allocation (FASB ASC 805) for each of the five entities and impairment testing (FASB ASC 350).
Marshall & Stevens was engaged to assist a long time client, Cloudbreak Health, with its merger with GigCapital2 (NYSE:GIX), a SPAC. That assignment grew to our being engaged to assist the SPAC with its merger with four other entities. The entity is now known as UpHealth, Inc. (NYSE:UPH).
Darleen Armour, ASA, Managing Director, Financial Valuation & Consulting, and her team in Los Angeles, and David Gaynor, ASA, CEIV, Managing Director, Healthcare Valuation, and his team in New York performed the requested valuation analyses.